Tag: Paul Jin
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
O’Melveny, Goodwin, White & Case in Samsung-eMagin merger
Three firms counsel Samsung Display and NYSE-listed eMagin in an agreement for the subsidiary of Samsung Electronics specialising in display products to acquire the American company for a USD218 million cash merger
